Clinical Trial Update: Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes

View source ↗

Summary

This single-center exploratory trial evaluated the RxSight Light Adjustable Lens and Light Delivery Device to improve visual outcomes in aphakia and cataract; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphakia
• Cataract

Drugs mentioned

• RxSight Light Adjustable Lens (LAL) (Light Adjustable Lens)
• RxSight Light Delivery Device (LDD) (Light Delivery Device)

Snippet

Sponsor: RxSight, Inc. | Conditions: Aphakia, Cataract | Status: COMPLETED | Results posted: 2025-02-10